Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002195
What this trial is testing

Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome 290
Post-approval studies (Phase 4)Study completedNCT02972723
What this trial is testing

Metformin Therapy in HCV Infection

Who this might be right for
Chronic Hepatitis C Infection
Nottingham University Hospitals NHS Trust 16
Not applicableUnknownNCT05170490
What this trial is testing

Long Term Follow up of Chronic HCV Patients Receiving DAAS

Who this might be right for
Chronic Hepatitis c
Sohag University 100
Large-scale testing (Phase 3)Ended earlyNCT04889040
What this trial is testing

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

Who this might be right for
COVID-19
Hoffmann-La Roche 216
Post-approval studies (Phase 4)Study completedNCT00637663
What this trial is testing

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

Who this might be right for
Hepatitis B, Chronic
Pusan National University Hospital 72
Not applicableUnknownNCT03268317
What this trial is testing

Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

Who this might be right for
Hepatitis C
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00038974
What this trial is testing

Hepatitis C Antiviral Resistance in African-Americans

Who this might be right for
Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 401
Testing effectiveness (Phase 2)Study completedNCT00617526
What this trial is testing

Naïve HIV POC Monotherapy Trial

Who this might be right for
HIV Infections
Ardea Biosciences, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT01435226
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 170
Post-approval studies (Phase 4)Looking for participantsNCT06792214
What this trial is testing

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
Mount Sinai Hospital, Canada 118
Early research (Phase 1)Ended earlyNCT01332552
What this trial is testing

A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects

Who this might be right for
Hepatitis C
GlaxoSmithKline 27
Not applicableLooking for participantsNCT06341543
What this trial is testing

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Who this might be right for
Cytomegalovirus InfectionsHeart TransplantationKidney Transplantation+2 more
University Hospital, Grenoble 288
Testing effectiveness (Phase 2)UnknownNCT05808335
What this trial is testing

Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)

Who this might be right for
Chronic Hepatitis B
ImmuneMed, Inc. 32
Early research (Phase 1)UnknownNCT04620291
What this trial is testing

Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults

Who this might be right for
HIV-1-infection
United BioPharma 18
Testing effectiveness (Phase 2)Study completedNCT00774397
What this trial is testing

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 719
Post-approval studies (Phase 4)Study completedNCT00948220
What this trial is testing

Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm 26
Post-approval studies (Phase 4)Study completedNCT04739410
What this trial is testing

Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients

Who this might be right for
Covid19
FMH College of Medicine and Dentistry 50
Not applicableStudy completedNCT05195060
What this trial is testing

TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

Who this might be right for
COVID-19
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,178
Early research (Phase 1)Study completedNCT01173224
What this trial is testing

Influenza Antiviral DAS181-F03

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT01473056
What this trial is testing

Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Akros Pharma Inc. 29
Next Page